Ki67 and PR to predict sensitivity of palbociclib: A real-world study.

doi:10.1200/JCO.2021.39.15_suppl.e13032

	Ki67 and PR to predict sensitivity of palbociclib: A real-world study.
	Shao, Xi-Ying ; Shen, Xia-Bo ; Li, Guang-Liang ; Zheng, Ya-Bing ; Cao, Wen-Ming ; Chen, Zhan-Hong ; Wang, Xiao-Jia
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2021-05-20
卷号	39
ISSN号	0732-183X
DOI	10.1200/JCO.2021.39.15_suppl.e13032
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000708120300149
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/126678]
专题	中国科学院合肥物质科学研究院
作者单位	1.Zhejiang Canc Hosp, Hangzhou, Peoples R China 2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Shao, Xi-Ying,Shen, Xia-Bo,Li, Guang-Liang,et al. Ki67 and PR to predict sensitivity of palbociclib: A real-world study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39.
APA	Shao, Xi-Ying.,Shen, Xia-Bo.,Li, Guang-Liang.,Zheng, Ya-Bing.,Cao, Wen-Ming.,...&Wang, Xiao-Jia.(2021).Ki67 and PR to predict sensitivity of palbociclib: A real-world study..JOURNAL OF CLINICAL ONCOLOGY,39.
MLA	Shao, Xi-Ying,et al."Ki67 and PR to predict sensitivity of palbociclib: A real-world study.".JOURNAL OF CLINICAL ONCOLOGY 39(2021).